It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.
The drug giant pours massive amounts into R&D -- nearly a quarter of its revenue. Seven of Merck's medications boast more than $1 billion in annual sales.

Is Merck Stock a Buy Now?

05:30am, Thursday, 10'th Aug 2023
Merck's crown jewel, Keytruda, is still the star of the show. There are other pieces to the company's business.

The 3 Best Healthcare Stocks to Buy in August

07:00pm, Wednesday, 09'th Aug 2023
Health is undoubtedly the most important thing for all of us. It's vital to be able to continue with our day-to-day and to be able to carry out everything we want to throughout our lives.
Shares in Ginkgo Bioworks jumped more than 7% in pre-market trading following the announcement of their collaboration with Merck & Co Inc (NYSE:MRK). The partnership aims to enhance biologics manufa
Shares in Ginkgo Bioworks jumped more than 7% in pre-market trading following the announcement of their collaboration with Merck & Co Inc (NYSE:MRK). The partnership aims to enhance biologics manufa
Ginkgo Bioworks Holdings Inc. shares DNA, were rising more than 5% in Monday's premarket trading after the company said it was collaborating with Merck & Co. Inc. MRK, -0.69% on improvements in biolog
Selling a call spread out of the money in a sideways-to-downside formation has high probabilities of expiring worthless.

Should You Buy Merck Stock After An Upbeat Q2?

09:00am, Thursday, 03'rd Aug 2023
The company posted upbeat Q2 results this week, with solid growth for Keytruda and Gardasil.
Verizon is a debt-laden telecom giant that just got a bit of extra bad news. Merck is complicated and still looks expensive despite the stock pullback.
The S&P 500 finished 0.3% lower on Tuesday, Aug. 1, 2023, as weaker-than-expected earnings from pharmaceutical companies weighed on the broader index.
Merck (MRK) beats Q2 estimates for earnings and sales. It raises its 2023 guidance.
Merck reported better-than-expected results and raised its sales outlook on rising drug and vaccine sales.
Although the revenue and EPS for Merck (MRK) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street esti
Stock markets looked poised to give back a little ground on the first day of August. Caterpillar reported solid growth in the second quarter, and shareholders expect more even in the face of macroecon
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE